Pages that link to "Item:Q4489920"
From MaRDI portal
The following pages link to The validation of surrogate endpoints in meta-analyses of randomized experiments (Q4489920):
Displayed 34 items.
- Choice of units of analysis and modeling strategies in multilevel hierarchical models (Q957034) (← links)
- Using earlier measures in a longitudinal sequence as a potential surrogate for a later one (Q962388) (← links)
- Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS (Q1020068) (← links)
- Exploring and validating surrogate endpoints in colorectal cancer (Q1029801) (← links)
- Center-within-trial versus trial-level evaluation of surrogate endpoints (Q1623614) (← links)
- Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials (Q1658329) (← links)
- An efficient algorithm to assess multivariate surrogate endpoints in a causal inference framework (Q2143008) (← links)
- Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption (Q2170431) (← links)
- Linear increment in efficiency with the inclusion of surrogate endpoint (Q2339530) (← links)
- Simplified modeling strategies for surrogate validation with multivariate failure-time data (Q2445595) (← links)
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials (Q2475730) (← links)
- Statistical evaluation of surrogate endpoints with examples from cancer clinical trials (Q2792764) (← links)
- Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials (Q2846433) (← links)
- A Shrinkage Approach for Estimating a Treatment Effect Using Intermediate Biomarker Data in Clinical Trials (Q2893404) (← links)
- Comparing Biomarkers as Principal Surrogate Endpoints (Q2893405) (← links)
- Meta-analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling (Q2894010) (← links)
- Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time (Q2894011) (← links)
- Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials (Q3076045) (← links)
- The Evaluation of Multiple Surrogate Endpoints (Q3078684) (← links)
- Principal Stratification in Causal Inference (Q3078899) (← links)
- A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker (Q3079026) (← links)
- Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints (Q3445296) (← links)
- Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach (Q3445321) (← links)
- On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints (Q3465713) (← links)
- A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials (Q3576929) (← links)
- On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm (Q3637000) (← links)
- Exploring the Relationship Between Surrogates and Clinical Outcomes: Analysis of Individual Patient Data vs. Meta-regression on Group-Level Summary Statistics (Q4430351) (← links)
- Advances in medical statistics arising from the AIDS epidemic (Q5424106) (← links)
- Surrogate Marker Evaluation from an Information Theory Perspective (Q5427415) (← links)
- Pairwise Fitting of Mixed Models for the Joint Modeling of Multivariate Longitudinal Profiles (Q5492080) (← links)
- Discussion on “Surrogate Measures and Consistent Surrogates” (Q5891277) (← links)
- A joint frailty‐copula model for meta‐analytic validation of failure time surrogate endpoints in clinical trials (Q6071311) (← links)
- Robust Approach to Combining Multiple Markers to Improve Surrogacy (Q6079767) (← links)
- Assurance in vaccine efficacy clinical trial design based on immunological responses (Q6085899) (← links)